Press release
Epoetin Alfa Therapeutics Market to See Incredible Growth During 2017 - 2025
Human erythropoietin is mostly produced by kidneys. It usually stimulates the human bone marrow to produce red blood cells. Inadequate production of human erythropoietin could lead to severe anemia. Epoetin alfa is an artificially made human erythropoietin. Developed by recombinant DNA technology, epoetin alfa acts as a catalyst to stimulate human erythropoietin production. Epoetin alfa is used to treat severe anemia, various neurological diseases, and cancer. It lowers the requirements of blood transfusion.
Download PDF Brochure of Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=40694
The global epoetin alfa therapeutics market is driven by high prevalence of anemia and neurological abnormalities, high diagnosis and treatment rate of cancer and anemia, favorable medical reimbursements, and strong health care infrastructure. High R&D investments and technological advancements are projected to propel the global epoetin alfa therapeutics market in the near future. However, side effects associated with epoetin alfa therapy such as joint pain, itching, headache, cough, rash, and nausea are anticipated to act as restraints of the global epoetin alfa therapy market during the forecast period.
Request to View TOC of Report –
https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=40694
Epoetin alfa therapy is mostly used to treat anemia and several types of cancer. According to a research published in the Current Treatment Options in Neurology, epoetin alfa has shown positive results in the treatment of traumatic brain injury, subarachnoid hemorrhage, and stroke. In terms of application, the global epoetin alfa therapeutics market can be segmented into anemia, cancer, neurology, and others. Based on route of administration, epoetin alfa therapeutics market can be classified into subcutaneous and intravenous. In terms of distribution channel, the global epoetin alfa therapeutics market has been divided into hospital pharmacies, retail pharmacies, drug stores and others.
Geographically, the global epoetin alfa therapeutics market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. A ten-year study on prevalence of anemia in the U.S. revealed that 3% to 5% of the U.S. population suffered from anemia in 2016. Prevalence of anemia in Europe was estimated at 6% to 7% in 2016. Moreover, a significant population of these two regions suffer from cancer and neurological disorders. High prevalence of anemia, neurological disorders, and cancer, high treatment cost, availability of medical reimbursement, well-established medical infrastructure, and technological advancements drive the epoetin alfa therapeutics market in North America and Europe. Asia Pacific is expected to account for the third largest share of the epoetin alfa therapeutics market. However, epoetin alfa therapeutics market in the region is anticipated to expand at the highest growth rate during the forecast period. This is attributed to large population, market penetration of epoetin alfa products, and technological developments. Furthermore, highest percentage of population suffer from anemia in Africa; more than 10% of the population of the region suffered from anemia in 2016. High prevalence of anemia, low awareness, lack of treatment of anemia, and unavailability of epoetin alfa products in Africa are the major factors that restrain epoetin alfa therapeutics market in Middle East & Africa.
Key players in the global epoetin alfa therapeutics market include Amgen, Inc., and Janssen Products, LP (a Johnson and Johnson Company).
Request to View Discount –
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=40694
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
More Trending Reports by Transparency Market Research:
Surgical Tables Market:
https://globenewswire.com/news-release/2018/02/28/1401258/0/en/Surgical-Tables-Market-to-be-worth-US-1-014-3-Million-by-2022-Transparency-Market-Research.html
Diabetes Drugs Market:
https://globenewswire.com/news-release/2018/03/05/1414894/0/en/Diabetes-Drugs-Market-to-be-worth-US-58-4-Billion-by-2025-Transparency-Market-Research.html
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Epoetin Alfa Therapeutics Market to See Incredible Growth During 2017 - 2025 here
News-ID: 1014649 • Views: …
More Releases from Transparency Market Research
Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 …
The global solar powered agricultural dryer market, valued at US$ 1.6 billion in 2022, is projected to grow at a CAGR of 5.8% from 2023 to 2031, reaching US$ 2.4 billion by the end of 2031. Rising investments in renewable energy, growing awareness of sustainable agricultural practices, and the rapid expansion of the agricultural sector driven by population growth are key factors fueling market growth.
Uncover essential discoveries and trends from…
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Ra …
The global Technetium‐99m Market was valued at US$ 6.0 Billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2034, surpassing US$ 8.6 Billion by the end of the forecast period. Advancements in nuclear imaging infrastructure, government-backed healthcare initiatives, and an increasing demand for precise diagnostic procedures are fueling this growth.
Discover essential conclusions and data from our Report in this sample -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77100
Analysts' Viewpoint
The Technetium‐99m…
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to …
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equine…
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of …
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,…
More Releases for Epoetin
Mircera (methoxy polyethylene glycol-epoetin beta) Market Size and Forecast
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Mircera (methoxy polyethylene glycol-epoetin beta) Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion.
Mircera (methoxy polyethylene glycol-epoetin beta) Market Size And Scope
The global Mircera (methoxy polyethylene glycol-epoetin beta) market is experiencing steady growth, driven by…
Epoetin-beta Erythropoietin Market Worldwide Industry Analysis, Future Demand an …
Epoetin-beta Erythropoietin Market Value reach $ million by 2029, registering a CAGR of 5.7% from 2023 to 2029. Erythropoietin (EPO)/hematopoietin is a glycoprotein hormone that triggers production of red blood cells in the bone marrow through erythropoiesis.
Important changes in the business allow key players to attain larger profits. This Epoetin-beta ErythropoietinMarket study report is the best way to make changes with the help of entire market condition and metrics provided…
Epoetin-alfa Erythropoietin Market to Witness Robust Expansion by 2029
Epoetin-alfa Erythropoietin Market Value expected to expand at a compound annual growth rate (CAGR) of 1.5% from 2023 to 2029. declining prices, and the development and approval of alternative products such as HIF prolyl-hydroxylase inhibitors are some of the key factors responsible for the slow market growth.
Important changes in the business allow key players to attain larger profits. This Epoetin-alfa ErythropoietinMarket study report is the best way to make changes…
Epoetin-beta Erythropoietin Market New Study Offers Insights for 2027 | Kyowa Ha …
This Epoetin-beta Erythropoietin market analysis will be extremely useful to business owners in streamlining their processes. It is the most valuable tool for business players since it allows them to develop and offer unique and sophisticated items to the market, enabling them to optimize their position in the market. It mentions purchasing, workforce development, inventory, and storage as some of the major industry development features. It also addresses the ever-changing…
Global Epoetin Beta Erythropoietin Market Size, Share and Trends Analysis Report …
The global epoetin beta erythropoietin market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). The primary factor driving the growth of the erythropoietin market is the increase in the prevalence of anemic conditions caused by end-stage renal disease treatment, chemotherapy, and antiretroviral treatment (ART). As a result, an increase in the number of chemotherapy treatment cycles, as well as an increase in the incidence of…
Epoetin (Eritropoyetin) Market Sluggish Growth Rate Foreseen by 2021-2027 with C …
Comprehensive business-related information is covered in the Epoetin (Eritropoyetin) market report such as price level, market trend, demand, supply and price index. It provides only market related data. It does not include any personal data. Another main goal of Epoetin (Eritropoyetin) market report is forecasting of future market trends according to current condition of the market. It greatly focuses on business forecast and depicts the future market growth of period…
